EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines

Hedieh Sattarifard iD, Marvellous Oyeyode, Dhanvi Prajapati iD, Angela Duaqui, Gurlovleen Kaur, Ishdeep Muker, Wenxia Luo, Ted M Lakowski iD, James R Davie iD

International Journal of Molecular Sciences · 24.07.2026 · 27 (15) · 6597

DOI: 10.3390/ijms27156597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.07.2026. Verfasst von Hedieh Sattarifard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB …. Hauptthemen laut MEDLINE: Bortezomib, Proteasome Inhibitors, Histones, Protein Processing, Post-Translational. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histone-modifying enzymes and histone post-translational modifications (PTMs) play key roles in the organization (euchromatin versus heterochromatin) and function (active versus silenced genes) of chromatin. The abundance and activity of these enzymes, along with their associated histone PTMs, are often altered in cancer cells, leading to deregulated gene expression. The expression of the KMT2A-MLLT3 protein, resulting from a chromosomal translocation in mixed-lineage leukemia (MLL), a subtype of acute myeloid leukemia, augments transcription elongation, promoting the expression of HOXA9 and MEIS1, genes that play critical roles in MLL development. Bortezomib, a proteasome inhibitor, has been effective at treating various cancers. In this study, we compared the impact of bortezomib on histone PTMs in the MLL cell line MOLM-13 and the chronic myeloid leukemic (CML) cell line K562. We report that MOLM-13 had a greater level of histone H2B monoubiquitinated at lysine 120 (H2BK120ub) and histone H3 dimethylated at lysine 79 (H3K79me2) (modifications involved in elongation) and similar levels of histone H2A monoubiquitinated at lysine 119 (H2AK119ub). Bortezomib treatment resulted in significant reductions in H2BK120ub and H2AK119ub levels, as well as in transcript levels of genes involved in MLL development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BortezomibProteasome InhibitorsHistonesProtein Processing, Post-TranslationalLeukemiaHistone CodeHumansCell Line, TumorUbiquitinationK562 Cells

Stichwörter der Autor:innen

bortezomibhistone H2A ubiquitinated at lysine 119histone H2B ubiquitinated at lysine 120proteasome

Substanzen

BortezomibProteasome InhibitorsHistones

Autor:innen und Institutionen

  • Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
  • Pharmaceutical Analysis Laboratory, College of Pharmacy, University of Manitoba, Winnipeg, MB R3E 0T5, Canada.

ORCID-Profile: Hedieh Sattarifard, Dhanvi Prajapati, Ted M Lakowski, James R Davie

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Sattarifard, H., Oyeyode, M., Prajapati, D., Duaqui, A., Kaur, G., Muker, I., Luo, W., Lakowski, T. M., & Davie, J. R. (2026). Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines. International Journal of Molecular Sciences, 27(15), 6597. https://doi.org/10.3390/ijms27156597

Vancouver

Sattarifard H, Oyeyode M, Prajapati D, Duaqui A, Kaur G, Muker I, et al. Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines. International Journal of Molecular Sciences. 2026;27(15):6597. doi:10.3390/ijms27156597

BibTeX
@article{Sattarifard2026,
  author = {Sattarifard, Hedieh and Oyeyode, Marvellous and Prajapati, Dhanvi and Duaqui, Angela and Kaur, Gurlovleen and Muker, Ishdeep and Luo, Wenxia and Lakowski, Ted M and Davie, James R},
  title = {Effect of the Proteasome Inhibitor, Bortezomib, on Histone Modifications in Human Leukemic Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6597},
  doi = {10.3390/ijms27156597}
}
Kostenlos starten →